<?xml version="1.0" encoding="UTF-8"?>
<ref id="B72-pharmaceutics-12-00171">
 <label>72.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gallant</surname>
    <given-names>J.E.</given-names>
   </name>
   <name>
    <surname>Gerondelis</surname>
    <given-names>P.Z.</given-names>
   </name>
   <name>
    <surname>Wainberg</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Shulman</surname>
    <given-names>N.S.</given-names>
   </name>
   <name>
    <surname>Haubrich</surname>
    <given-names>R.H.</given-names>
   </name>
   <name>
    <surname>St Clair</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Lanier</surname>
    <given-names>E.R.</given-names>
   </name>
   <name>
    <surname>Hellmann</surname>
    <given-names>N.S.</given-names>
   </name>
   <name>
    <surname>Richman</surname>
    <given-names>D.D.</given-names>
   </name>
  </person-group>
  <article-title>Nucleoside and nucleotide analogue reverse transcriptase inhibitors: A clinical review of antiretroviral resistance</article-title>
  <source>Antivir. Ther.</source>
  <year>2003</year>
  <volume>8</volume>
  <fpage>489</fpage>
  <lpage>506</lpage>
  <pub-id pub-id-type="pmid">14760883</pub-id>
 </element-citation>
</ref>
